ONCR-719

N/A

Report date: 2025/01/03 10:08:38

Base Information

Drug NameONCR-719
Drug Alias NameONCR-GBMONCR-719
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionInterleukin-12 replacementsAnti-PD-115-hydroxyprostaglandin dehydrogenase [NAD(+)] gene transference +[4] 
TargetsInterleukin-12Programmed cell death protein 115-hydroxyprostaglandin dehydrogenase [NAD(+)]
Therapy Area/IndicationsCentral Nervous System NeoplasmsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncorus Inc
China Registration ClassN/A

Develop Information

Active CompaniesOncorus Inc
Inactive CompaniesN/A
Active IndicationsCentral Nervous System NeoplasmsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A